BE903128A - Derives de benzimidazole procede pour leur preparation et agents anti-ulceres en contenant - Google Patents
Derives de benzimidazole procede pour leur preparation et agents anti-ulceres en contenantInfo
- Publication number
- BE903128A BE903128A BE0/215506A BE215506A BE903128A BE 903128 A BE903128 A BE 903128A BE 0/215506 A BE0/215506 A BE 0/215506A BE 215506 A BE215506 A BE 215506A BE 903128 A BE903128 A BE 903128A
- Authority
- BE
- Belgium
- Prior art keywords
- group
- preparation
- agents containing
- benzimidazole derivatives
- hydrogen atom
- Prior art date
Links
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 title 1
- 239000003699 antiulcer agent Substances 0.000 title 1
- 150000001556 benzimidazoles Chemical class 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Des dérives de benzimodazole de formule (I) dans laquelle R1 représente un atome d'hydrogène, un groupe alkyle en C1-C8, un groupe cycloalkyle, un groupe phényle ou un groupe aralkyle, R2 représente un atome d'hydrogène ou un groupe alkyle en C1-C8, ou encore R1 et R2 forment un noyau ensemble avec l'atome d'azote adjacent, tandis que R3 et R4 représentent chacun un atome d'hydrogène, un atome d'halogène, un groupe trifluorométhyle, un groupe alkyle inférieur, un groupe alcoxy inférieur, un groupe alcoxy inférieur-carbonyle ou un groupe amino, ces dérivés étant efficaces contre les ulcères.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59182400A JPS6160660A (ja) | 1984-08-31 | 1984-08-31 | ベンズイミダゾ−ル誘導体およびその製造法ならびにこれを含有する抗潰瘍剤 |
| JP60061195A JPH0764826B2 (ja) | 1985-03-26 | 1985-03-26 | ベンズイミダゾール誘導体 |
| JP60061194A JPH068283B2 (ja) | 1985-03-26 | 1985-03-26 | ベンズイミダゾ−ル誘導体およびその製造法ならびにこれを含有する抗潰瘍剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE903128A true BE903128A (fr) | 1985-12-16 |
Family
ID=27297422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/215506A BE903128A (fr) | 1984-08-31 | 1985-08-27 | Derives de benzimidazole procede pour leur preparation et agents anti-ulceres en contenant |
Country Status (14)
| Country | Link |
|---|---|
| KR (1) | KR920004936B1 (fr) |
| AR (1) | AR242195A1 (fr) |
| AU (3) | AU4640985A (fr) |
| BE (1) | BE903128A (fr) |
| BR (1) | BR8504252A (fr) |
| CH (1) | CH665417A5 (fr) |
| DE (1) | DE3531487C2 (fr) |
| ES (1) | ES8703142A1 (fr) |
| FR (1) | FR2569691B1 (fr) |
| GB (1) | GB2163747B (fr) |
| IT (1) | IT1189601B (fr) |
| MX (1) | MX159807A (fr) |
| NL (1) | NL8502384A (fr) |
| SE (1) | SE500669C2 (fr) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4687775A (en) * | 1986-07-17 | 1987-08-18 | G. D. Searle & Co. | 2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles |
| US4721718A (en) * | 1986-08-18 | 1988-01-26 | G. D. Searle & Co. | 2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers |
| US4772619A (en) * | 1986-07-17 | 1988-09-20 | G. D. Searle & Co. | [(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8417194D0 (en) * | 1984-07-05 | 1984-08-08 | Boots Co Plc | Therapeutic agents |
| CA1341314C (fr) | 1984-07-06 | 2001-11-06 | David Cox | Derives de benzimidazole, benzothiazole et benzoxazole |
| GB2161160B (en) * | 1984-07-06 | 1989-05-24 | Fisons Plc | Heterocyclic sulphinyl compounds |
| US5869513A (en) * | 1985-05-24 | 1999-02-09 | G. D. Searle & Co. | 2- (1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines |
| AU5768886A (en) * | 1985-05-24 | 1986-11-27 | G.D. Searle & Co. | 2-((1-h-benzimidazol-2-ylsulfinyl)methyl)benzenamines |
| US4824856A (en) * | 1985-08-14 | 1989-04-25 | Nippon Chemiphar Co., Ltd. | Method of protecting gastrointestinal tract |
| EP0232399A1 (fr) * | 1985-08-21 | 1987-08-19 | Byk Gulden Lomberg Chemische Fabrik GmbH | Nouvelles amines, leur procede de fabrication, leur utilisation, et medicaments les contenant |
| AR243167A1 (es) | 1985-08-24 | 1993-07-30 | Hoechst Ag | Procedimiento para la preparacion de toluidinas sustituidas. |
| AU619444B2 (en) * | 1986-06-02 | 1992-01-30 | Nippon Chemiphar Co. Ltd. | 2-(2-aminobenzylsulfinyl)- benzimidazole derivatives |
| EP0251536A1 (fr) * | 1986-06-24 | 1988-01-07 | FISONS plc | Benzimidazoles, leur préparation, formulation et utilisation comme inhibiteurs de sécrétion d'acide gastrique |
| DE3639926A1 (de) * | 1986-11-22 | 1988-06-01 | Hoechst Ag | Substituierte thienoimidazoltoluidin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer |
| IT1222412B (it) * | 1987-07-31 | 1990-09-05 | Chiesi Farma Spa | Tiometil e sulfinil metil derivati ad azione antisecretiva acida gastrica,loro procedimento di preparazione e composizioni farmaceutiche che li contengono |
| JP2614756B2 (ja) * | 1988-08-10 | 1997-05-28 | 日本ケミファ株式会社 | イミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤 |
| JPH06298611A (ja) * | 1993-04-16 | 1994-10-25 | Nippon Chemiphar Co Ltd | 抗菌剤 |
| SE9301489D0 (sv) | 1993-04-30 | 1993-04-30 | Ab Astra | Veterinary composition |
| SE9402431D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
| SE9500422D0 (sv) * | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
| SE9500478D0 (sv) * | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
| US5708017A (en) * | 1995-04-04 | 1998-01-13 | Merck & Co., Inc. | Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors |
| HRP960232A2 (en) * | 1995-07-03 | 1998-02-28 | Astra Ab | A process for the optical purification of compounds |
| ATE286394T1 (de) * | 1995-09-21 | 2005-01-15 | Pharma Pass Ii Llc | Ein säurelabile omeprazol enthaltende arzneizusammensetzung und verfahren zu deren herstellung |
| SE9600070D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
| US6380222B2 (en) | 1996-10-11 | 2002-04-30 | Astrazeneca Ab | Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps |
| ES2232015T3 (es) | 1997-07-25 | 2005-05-16 | Altana Pharma Ag | Inhibidor de las bombas de protones en combinacion terapeutica con sustancias antibacterianas. |
| SE9704869D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulaton II |
| SE9704870D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulation I |
| US7041313B1 (en) | 1998-08-12 | 2006-05-09 | Altana Pharma Ag | Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles |
| AU1054899A (en) * | 1998-11-06 | 2000-05-29 | Dong-A Pharmaceutical Co., Ltd. | Method of preparing sulfide derivatives |
| TWI243672B (en) | 1999-06-01 | 2005-11-21 | Astrazeneca Ab | New use of compounds as antibacterial agents |
| EE200100660A (et) | 1999-06-07 | 2003-04-15 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Ravimvorm happe suhtes labiilsete toimeainete jaoks, toimeaine üksus, selle valmistamismeetod ja mikrokerake |
| SE9903831D0 (sv) | 1999-10-22 | 1999-10-22 | Astra Ab | Formulation of substituted benzimidazoles |
| SE0000774D0 (sv) | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
| US6544556B1 (en) | 2000-09-11 | 2003-04-08 | Andrx Corporation | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
| SE0101379D0 (sv) | 2001-04-18 | 2001-04-18 | Diabact Ab | Komposition som hämmar utsöndring av magsyra |
| US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
| SE0102993D0 (sv) | 2001-09-07 | 2001-09-07 | Astrazeneca Ab | New self emulsifying drug delivery system |
| US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| JP4732696B2 (ja) | 2002-04-09 | 2011-07-27 | フラメル・テクノロジー | 活性成分の改変された放出のための、マイクロカプセルの水性懸濁液形態での経口医薬品製剤 |
| ES2314227T7 (es) | 2002-04-09 | 2012-11-19 | Flamel Technologies | Formulacion farmaceutica oral en forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de amoxilicina. |
| SE0203065D0 (sv) | 2002-10-16 | 2002-10-16 | Diabact Ab | Gastric acid secretion inhibiting composition |
| WO2004112756A1 (fr) | 2003-06-26 | 2004-12-29 | Isa Odidi | Capsules contenant un inhibiteur de la pompe a protons comprenant des unites secondaires differemment structurees permettant une liberation retardee de l'ingredient actif |
| KR20060092255A (ko) | 2003-09-26 | 2006-08-22 | 알자 코포레이션 | 고도의 약물적재를 제공하는 약물코팅제 및 그의 제조방법 |
| US8394409B2 (en) | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
| US20060024362A1 (en) | 2004-07-29 | 2006-02-02 | Pawan Seth | Composition comprising a benzimidazole and process for its manufacture |
| US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
| US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
| US7803817B2 (en) | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
| US7981908B2 (en) | 2005-05-11 | 2011-07-19 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion |
| US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
| CN104825397A (zh) | 2006-04-03 | 2015-08-12 | 伊萨·奥迪迪 | 含有机溶胶涂层的受控释放递送物件 |
| US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
| EP2046334B1 (fr) | 2006-07-25 | 2014-05-21 | Vecta Ltd. | Compositions et procédés d'inhibition de sécrétion d'acide gastrique utilisant des dérivés de petits acides dicarboxyliques combinés á un ipp |
| WO2008080092A2 (fr) | 2006-12-22 | 2008-07-03 | Ironwood Pharmaceuticals, Inc. | Méthodes et compositions pour le traitement de troubles oesophagiens |
| KR20110079641A (ko) | 2008-09-09 | 2011-07-07 | 아스트라제네카 아베 | 제약 조성물을 이를 필요로 하는 환자에게 전달하는 방법 |
| MX2011013467A (es) | 2009-06-25 | 2012-02-13 | Astrazeneca Ab | Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine). |
| WO2011080500A2 (fr) | 2009-12-29 | 2011-07-07 | Orexo Ab | Nouvelle forme pharmaceutique destinée au traitement de troubles liés à l'acide gastrique |
| WO2011080502A2 (fr) | 2009-12-29 | 2011-07-07 | Orexo Ab | Nouvelle forme pharmaceutique destinée au traitement de troubles liés à l'acide gastrique |
| US20120294937A1 (en) | 2009-12-29 | 2012-11-22 | Novartis Ag | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
| WO2012027331A1 (fr) | 2010-08-27 | 2012-03-01 | Ironwood Pharmaceuticals, Inc. | Compositions et procédés pour traiter ou prévenir un syndrome métabolique et des maladies et troubles associés |
| EP2601947A1 (fr) | 2011-12-05 | 2013-06-12 | Abo Bakr Mohammed Ali Al-Mehdar | Combinaison à dose fixe pour le traitement de maladies associées à Hélicobacter pylori |
| US9539214B2 (en) | 2011-12-28 | 2017-01-10 | Pozen Inc. | Compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
| EA201591338A1 (ru) | 2013-01-15 | 2016-01-29 | Айронвуд Фармасьютикалз, Инк. | Гастроретентивная лекарственная форма секвестранта желчных кислот с замедленным высвобождением для перорального применения |
| EP2801565B1 (fr) | 2013-05-06 | 2015-07-22 | King Saud University | Composés destinés à être utilisés en tant qu'agent antiulcéreux et/ou agent anti-helicobacter pylori et leurs compositions pharmaceutiques |
| US20180015118A1 (en) | 2015-02-03 | 2018-01-18 | Ironwood Pharmaceuticals, Inc. | Methods of treating upper gastrointestinal disorders in ppi refractory gerd |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4359465A (en) * | 1980-07-28 | 1982-11-16 | The Upjohn Company | Methods for treating gastrointestinal inflammation |
| CA1341314C (fr) * | 1984-07-06 | 2001-11-06 | David Cox | Derives de benzimidazole, benzothiazole et benzoxazole |
-
1985
- 1985-08-19 AU AU46409/85A patent/AU4640985A/en not_active Abandoned
- 1985-08-27 BE BE0/215506A patent/BE903128A/fr not_active IP Right Cessation
- 1985-08-27 ES ES546445A patent/ES8703142A1/es not_active Expired
- 1985-08-29 CH CH3709/85A patent/CH665417A5/fr not_active IP Right Cessation
- 1985-08-29 GB GB08521493A patent/GB2163747B/en not_active Expired
- 1985-08-30 SE SE8504048A patent/SE500669C2/sv unknown
- 1985-08-30 BR BR8504252A patent/BR8504252A/pt unknown
- 1985-08-30 MX MX206462A patent/MX159807A/es unknown
- 1985-08-30 AR AR85301474A patent/AR242195A1/es active
- 1985-08-30 IT IT67743/85A patent/IT1189601B/it active
- 1985-08-30 NL NL8502384A patent/NL8502384A/nl not_active Application Discontinuation
- 1985-08-30 KR KR1019850006307A patent/KR920004936B1/ko not_active Expired
- 1985-08-30 FR FR858512961A patent/FR2569691B1/fr not_active Expired
- 1985-08-30 DE DE3531487A patent/DE3531487C2/de not_active Expired - Fee Related
-
1989
- 1989-09-11 AU AU41271/89A patent/AU4127189A/en not_active Abandoned
-
1992
- 1992-11-27 AU AU29750/92A patent/AU647978B2/en not_active Ceased
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4687775A (en) * | 1986-07-17 | 1987-08-18 | G. D. Searle & Co. | 2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles |
| US4772619A (en) * | 1986-07-17 | 1988-09-20 | G. D. Searle & Co. | [(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines |
| US4721718A (en) * | 1986-08-18 | 1988-01-26 | G. D. Searle & Co. | 2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers |
Also Published As
| Publication number | Publication date |
|---|---|
| ES8703142A1 (es) | 1986-11-16 |
| IT1189601B (it) | 1988-02-04 |
| SE8504048L (sv) | 1986-03-01 |
| AU647978B2 (en) | 1994-03-31 |
| AU4640985A (en) | 1986-03-06 |
| FR2569691A1 (fr) | 1986-03-07 |
| SE8504048D0 (sv) | 1985-08-30 |
| AR242195A1 (es) | 1993-03-31 |
| DE3531487C2 (de) | 1995-08-17 |
| CH665417A5 (fr) | 1988-05-13 |
| GB2163747B (en) | 1989-02-08 |
| ES546445A0 (es) | 1986-11-16 |
| KR860001793A (ko) | 1986-03-22 |
| SE500669C2 (sv) | 1994-08-08 |
| BR8504252A (pt) | 1986-06-17 |
| MX159807A (es) | 1989-08-31 |
| NL8502384A (nl) | 1986-03-17 |
| AU2975092A (en) | 1993-01-28 |
| IT8567743A0 (it) | 1985-08-30 |
| GB8521493D0 (en) | 1985-10-02 |
| DE3531487A1 (de) | 1986-03-13 |
| AU4127189A (en) | 1989-12-21 |
| KR920004936B1 (ko) | 1992-06-22 |
| FR2569691B1 (fr) | 1989-08-04 |
| GB2163747A (en) | 1986-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3677452D1 (de) | Chinazolinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| BE901224A (fr) | Nouveaux derives d'indole utiles comme medicaments et intermediaires et procedes pour leur preparation. | |
| BE1002211A4 (fr) | (pentamethyl-1,2,2,6,6 piperidyl-4-amino)-triazines, leur application comme stabilisants de matieres organiques, et compositions qui en contiennent. | |
| SE8204817D0 (sv) | Tetrazine derivatives | |
| BE903778A (fr) | Derives d'indoles. | |
| AU581438B2 (en) | Substituted pyrrolidinones, processes for their preparation and pharmaceutical compositions | |
| BE900275A (fr) | Azetidinones. | |
| BE901987A (fr) | Derives d'alcanolamines et inhibiteurs de l'agregation des plaquettes en contenant comme principe actif. | |
| ATE179416T1 (de) | 1-(arylalkyl-aminoalkyl) imidazolderivate, herstellungs verfahren und verwendung als therapeutische mittel | |
| BE904641A (fr) | 5-pyrimidine-carboxamides et traitement de la leucemie et des tumeurs avec ces derniers. | |
| BE902710A (fr) | Procede stereospecifique pour la preparation d'azetidinones. | |
| DK283984D0 (da) | Benzodiazepinderivater og fremgangsmaade til fremstilling deraf | |
| BE900183A (fr) | N-dichloracetyl-glycinamides substituees sur n et eventuellement sur n' et leur utilisation comme antidotes dans les herbicides. | |
| BE1002181A3 (fr) | 3-(2-haloalkyl)-1,4-oxathiines et 2-(2-haloalkyl)-1,4-dithiines, de meme que le traitement de la leucemie et des tumeurs avec ces substances. | |
| BE905340A (fr) | Derives du methylene-dioxy-phenanthrene et du stilbene, procede pour leur preparation et medicaments les contenant. | |
| BE902150A (fr) | Derives de la 1h, 7h-pyrazolo (1,5-a) pyrimidine-7-one et procede pour leur preparation. | |
| BE904409Q (fr) | Nouveaux colorants cupriferes et leur preparation. | |
| BE905297A (fr) | Derives heterocycliques. | |
| BE1003314A3 (fr) | Procede de dedoublement d'intermediaires interessants dans la preparation de diltiazem. | |
| BE904016A (fr) | Nouveaux derives naphtaleniques du benzonorbornene, leur procede de preparation et compositions medicamenteuse et cosmetique les contenant | |
| GB949228A (en) | The manufacture of new indole derivatives | |
| BE901072A (fr) | Procede de decarbonylation selective. | |
| BE900882A (fr) | Derives de 2h-azeto(2,1-a)-isoquinoleine, procede pour les preparer et compositions pharmaceutiques les contenant. | |
| BE900618A (fr) | Derives de 4,5,6,7-tetrahydrobenzimidazole. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: NIPPON CHEMIPHAR CO. LTD Effective date: 20000831 |